Microbiome helps identify who benefits from combination immunotherapy

[ad_1] A new study by researchers at the Wellcome Sanger Institute, the Olivia Newton-John Cancer Research Institute in Australia and collaborators has identified specific strains of bacteria that are linked to a positive response to combination immunotherapy in the largest study of its kind. . The study is published in Nature medicine In an article … Read more